Pharmacokinetics and pharmacodynamics of sunitinib for the treatment of advanced pancreatic neuroendocrine tumors

Author： Bisht Savita   Feldmann Georg   Brossart Peter  

Publisher： Informa Healthcare

ISSN： 1742-5255

Source： Expert Opinion on Drug Metabolism and Toxicology, Vol.9, Iss.6, 2013-06, pp. : 777-788

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Everolimus for the treatment of pancreatic neuroendocrine tumors

By Feldmann Georg   Bisht Savita   Schütte Ute   Haarmann Jens   Brossart Peter  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 14, 2012-10 ,pp. : 2073-2084

Informa Healthcare

Access to resources Recommend Favorite

Emerging therapies for the treatment of patients with advanced neuroendocrine tumors

By Chan Jennifer A   Kulke Matthew H  

Expert Opinion on Emerging Drugs, Vol. 12, Iss. 2, 2007-05 ,pp. : 253-270

Informa Healthcare

Access to resources Recommend Favorite

Pancreatic neuroendocrine tumors in twelve baboons (Papio spp.)

By  

JOURNAL OF MEDICAL PRIMATOLOGY, Vol. 45, Iss. 2, 2016-04 ,pp. : 85-91

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Pharmacokinetics and Pharmacodynamics of Levodopa in the Treatment of Parkinson's Disease

By  

Current Clinical Pharmacology, Vol. 2, Iss. 3, 2007-01 ,pp. : 234-243

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacodynamics and Pharmacokinetics of Antifungals for Treatment of Invasive Aspergillosis

By  

Current Pharmaceutical Design, Vol. 19, Iss. 20, 2013-06 ,pp. : 3629-3647

Bentham Science Publishers

Access to resources Recommend Favorite